Site Search
Company Search
Get Quote
"The QualityStocks Daily", our free summary formatted newsletter containing stock tips from hundreds of online investment newsletters.
QualityStocksNewsBreaks
- 3:30 pm QualityStocksNewsBreaks – Silver Opportunity: New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Unlocks Value from Flagship Projects
- 3:20 pm QualityStocksNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Leveraging Crypto to Bridge New World and Classic Industry
- 3:00 pm QualityStocksNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Charts Dual-Path for NRX-100
QualityStocks Articles
- 3:10 pm QualityStocksNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Poised at the Crossroads of Clean Energy and Critical Minerals
- 10:30 am D-Wave Quantum Inc. (NYSE: QBTS) Secures $400 Million in Equity Offering, Eyes Acquisitions and Expansion
- 9:45 am ONAR Holding Corp. (ONAR): A Strategic Pivot Toward Scalable, High-Margin Growth
QualityStocksSpotlight Company
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
Investment Considerations Scinai has an exclusive worldwide license to commercialize inhalable NanoAbs for the treatment of COVID-19. The inhaled NanoAbs led to shorter and milder illness, and protected against illness, in vivo. Scinai has exclusive options for worldwide licenses for NanoAbs to treat other disorders with large, underserved needs, including psoriasis. The company further hedges … Continue reading “Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)”
Latest Press Releases
Filter Releases
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |
Interested in a live, online demonstration?
Get a walkthrough of our products and services.
- Recognize the difference of our innovative, all-encompassing approach
- See how we will drive results for your company
- Understand the power of our partnerships to extend your reach and recognition in the investment community and beyond
